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Abstract
The Roux-en-Y gastric bypass (RYGB) remains the most effective treatment for morbidly
obese patients to lower body weight and improve glycemic control. There is recent evi-
dence that the mycobiome (fungal microbiome) can aggravate disease severity in a num-
ber of diseases including inflammatory bowel disease (IBD), irritable bowel syndrome
(IBS) and hepatitis; moreover, a dysbiotic fungal microbiota has been reported in the
obese. We characterized fungal and bacterial microbial composition in fecal samples of
16 morbidly obese patients before and three months after RYGB surgery and compared
with nine healthy controls. We found that RYGB surgery induced a clear alteration in
structure and composition of the gut fungal and bacterial microbiota. Beta diversity analy-
sis revealed significant differences in bacterial microbiota between obese patients before
surgery and healthy controls (P < 0.005) and a significant, unidirectional shift in RYGB
patients after surgery (P < 0.001 vs. before surgery). In contrast, there was no significant
difference in fungal microbiota between groups but individually specific changes after
RYGB surgery. Interestingly, RYGB surgery induced a significant reduction in fungal
alpha diversity namely Chao1, Sobs, and Shannon diversity index (P<0.05, respectively)
which contrasts the trend for uniform changes in bacteria towards increased richness and
diversity post-surgery. We did not observe any inter-kingdom relations in RYGB patients
but in the healthy control cohort and there were several correlations between fungi and
bacteria and clinical parameters (P<0.05, respectively) that warrant further research. Our
study identifies changes in intestinal fungal communities in RYGB patients that are dis-
tinct to changes in the bacterial microbiota.
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Mayenfisch-Foundation, Zürich, Switzerland. RES:
UNISCIENTIA STIFTUNG, VADUZ, Zurich,
Switzerland The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
s
o
u
r
c
e
:
 
h
t
t
p
s
:
/
/
d
o
i
.
o
r
g
/
1
0
.
7
8
9
2
/
b
o
r
i
s
.
1
4
9
3
1
4
 
|
 
d
o
w
n
l
o
a
d
e
d
:
 
2
7
.
1
2
.
2
0
2
0
Introduction
The Roux-en-Y gastric bypass (RYGB) remains the most effective treatment for morbidly
obese patients to lower body weight and improve glycemic control [1]. Several interrelated
mechanism have been suggested for this including alterations in the postprandial secretion of
gastrointestinal hormones [2, 3], increased delivery of bile acid salts to distal L-cells [2, 4],
faster gastric transit and changes in vagal nerve signaling [5] and, more recently, changes in
gut microbiota composition [6]. The gut microbiota is a dense and highly diverse microbial
community composed of bacteria, fungi, phages, viruses, protozoa, and archaea that inhabits
the gastrointestinal tract and is intimately involved in host physiology [7, 8]. An impairment
of the gut microbiota, referred to as ‘dysbiosis’ and characterized by changes in its composition
and function, is commonly observed in gastrointestinal and systemic diseases [9, 10]. In the
obese, bacterial dysbiosis is characterized by compositional changes in specific bacterial groups
and low bacterial gene richness and related functional pathways [11–13]. RYGB surgery
restores bacterial richness and diversity and substantially alters the abundance of several bacte-
rial groups [14–16]. It has been speculated that these alterations may support weight loss and
metabolic improvements seen after surgery.
The fungal components of the gut microbiota have hardly been explored in health and dis-
ease. Fungi comprise less than 2% of total gut microorganisms, with only about 60 genera and
180 species [17]. A fungal cell is, however, about >100-fold larger than a bacterial cell and
thus, represents substantially greater biomass than suggested by the number of available
genomes [17]. Mycobiome dysbiosis has recently been implicated in the pathogenesis of
inflammatory bowel diseases (IBD) [18], irritable bowel syndrome (IBS) [19] and hepatitis
[20] and Rodrı́guez et al. [21] observed an increased abundance of Ascomycota, Saccharomy-
cetes, Dipodascaceae and Saccharomycetaceae in the obese [21]. To date, it has not been
explored whether RYGB surgery has an impact on fungal microbiota and whether potential
changes are related to the metabolic improvements postoperatively.
Here we used an amplicon-based barcoding approach to characterize fungal and bacterial
microbiota in fecal samples of morbidly obese patients before and three months after RYGB
surgery and healthy, normal-weight controls. We applied a variety of analyses to assess differ-
ences in microbial community composition, possible inter-kingdom correlations, and rela-
tionships with clinical patient parameters.
Materials and methods
Patients and sample collection
Sixteen RYGB patients were recruited at the Department of Surgery, University Hospital
Zurich, Switzerland. Each participant gave written, informed consent before participating in
the study. All patients underwent complete evaluation before the operation and during follow-
up, including medications, nutritional behavior, anthropometric and clinical parameters, and
blood sampling for laboratory tests. RYGB patients received surgery between July and Septem-
ber 2017. Fecal samples were collected the day before surgery and three months after, using
the deoxyribose nucleic acid (DNA) Genotek Omnigene Gut Collection kits (DNA Genotek,
Ontario, Canada) following the manufacturer’s instructions. The kits were returned to a −80
˚C freezer within 24 h of collection and stored until analysis.
A separate cohort of Dutch healthy normal weight subjects was used as a baseline. This
approach was implied to see the direction of microbial changes after RYGB surgery towards, or
against a healthy microbiome profile. Normal-weight controls were nine non-smokers, non-
drug using individuals from the Netherlands who did not regularly experience intestinal
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problems and were not under treatment for conditions or diseases of the digestive tract. Healthy
subjects had not taken antibiotics for at least seven months before sampling, nor had they used
other medications in the previous two weeks. Each participant gave written, informed consent
before participating in the study.
Subject characteristics are presented in Table 1. All research was carried out in compliance
with the Helsinki Declaration, and for the Swiss RYGB cohort, it was approved by the ethics
committee Zurich, Switzerland (BASEC Nr. 2012–0260) while for the healthy Dutch controls
it was approved by the ethics committee Brabant, The Netherlands.
DNA isolation, amplicon PCR and illumina sequencing
DNA was extracted from fecal samples, as described previously [22]. DNA samples were then
used for the 16S rRNA gene and Internal Transcribed Spacer (ITS) region sequencing to char-
acterize bacterial and fungal communities (for details, see S1 File).
Microbiome (16S and ITS) data analysis
The 16S rRNA gene and ITS sequencing data were pre-processed, analyzed, and classified
using Mothur (v. 1.36.1) [23]. Low-quality regions of the 16S rRNA gene sequences were
trimmed using Btrim [24] with a sliding window size of 5 nucleotide and an average quality
score of 25. For the ITS sequences, cutadapt was used for trimming [25] with a quality cutoff
of 20. Paired-end reads were merged, and unique sequences were filtered based on length,
with no ambiguous bases allowed. Chimeric sequences were identified and removed using
UCHIME (Edgar 2011). Unique 16S rRNA gene sequences were aligned to the bacterial
SILVA SEED reference database (Release 128, available at https://mothur.org/wiki/Silva_
reference_files). Taxonomic assignment was performed using the Ribosomal Database Project
(RDP) naïve Bayesian classifier with a confidence threshold of 60% and 1000 iterations [26]
and the mothur-formatted version of the RDP training set v.14 (trainset14_032015). Unique
ITS sequences were classified using the UNITE reference database v.6 (mothur release, avail-
able at https://unite.ut.ee/repository.php), with a confidence threshold of 60% and 1000
Table 1. Subject characteristics.
Healthy controls (n = 9) RYGB patients (before surgery, n = 16) RYGB patients (3 month after surgery, n = 16)
Age (yr) 49.8 ± 5.0 (22–64)a 39.8 ± 3.1 (22–67)a 39.8 ± 3.1 (22–67)a
Gender (m/f) 5/4 5/11 5/11
Weight (kg) 75.0 ± 4.3 (60–95)a 119 ± 6.0 (93–169)b 96.9 ± 5.4 (78–136)c
BMI (kg/m2) 22.5 ± 0.8 (20.3–26.9)a 41.6 ± 1.4 (35.6–51.9)b 33.9 ± 1.4 (24.3–43.7)c
Hip-to-Waist Ratio - 1.1 ± 0.1 (0.9–1.2)a 1.1 ± 0.1 (0.9–1.3)a
Hemoglobin A1c (%) - 5.5 ± 0.1 (5.1–6.2)a 5.1 ± 0.1 (4.8–5.5)b
Fasting glucose (mmol/L) - 5.7 ± 0.2 (4.4–7.2)a 4.6 ± 0.1 (3.6–5.4)b
Total cholesterol (mmol/l) - 4.4 ± 0.2 (2.9–6.1)a 3.7 ± 0.2 (2.7–5.0)b
HDL-cholesterol (mmol/l - 1.1 ± 0.2 (0.8–1.5)a 1.2 ± 0.1 (0.7–1.6)a
LDL-cholesterol (mmol/l) - 2.7 ± 0.2 (1.8–4.1)a 2.0 ± 0.1 (1.1–2.8)b
Triglyceride (mmol/l) - 1.7 ± 0.3 (0.7–5.4)a 1.1 ± 0.1 (0.7–1.8)a
C-reactive protein (mg/L) - 6.6 ± 1.2 (0.7–19.0)a 4.5 ± 1.3 (0.8–20.0)a
BMI, body mass index; HDL, high-density-lipoprotein; LDL, low-density lipoprotein; Data presented as mean ± standard error of mean, with ranges in parentheses.
Means with different letter superscripts differ significantly between groups, P<0.05. To test for significant differences between groups, comparisons used Student’s
independent and paired t-test.
https://doi.org/10.1371/journal.pone.0236936.t001
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iterations. 16S rRNA gene and ITS sequence data have been submitted to the European Nucle-
otide Archive (accession no. PRJEB38917).
Statistical analysis
Statistical analysis was conducted using the open source software R, version 3.5.1 [27], and fig-
ures were generated using ggplot2 [28]. Descriptive statistics were used for demographic vari-
ables of the RYGB and heathy control cohort. To test for significant differences between
groups, comparisons used Student’s independent and paired t-test. Differences in bacterial
and fungal community composition between the sample groups were assessed at the phylum,
class, family and genus level using the DESeq2 package (Love 2014). The Benjamini-Hochberg
(BH) false discovery rate (FDR) correction was applied to the resulting p-values [29]. Microbial
alpha diversity estimations are known to be influenced by sequencing depth. Thus, to rarify
this uneven sequencing depths, subsampling (bacterial 11514 seqeunces per samples and
mycobiome 98 sequences per sample) approach was implemented to calculate four diversity
indices.: (i) Abundance-based Coverage Estimator (ACE) metric, (ii) Chao1, (iii) observed
species, and (iv) Shannon’s diversity. Analysis of variance (ANOVA) was performed to test
global differences in diversity among groups, in addition, paired t-tests was applied to compare
RYGB patinets before and after surgery. For beta diversity analysis, due to uneven sampling
depth (library size), the microbiome data was normalized using the variance stabilizing trans-
formation (VST) method in the DESeq2 package. The transformed data was analyzed with
PerMANOVA using the adonis function of the package vegan in R (http://cc.oulu.fi/~jarioksa/
softhelp/vegan/html/adonis.html) to determine community composition variation across
groups at different taxonomic levels. P-value adjustment was done via p.adjust function using
the Benjamini & Hochberg method. Spearman correlation analysis was used to explore the
relationship between changes in bacterial and fungal communities, and between these changes
and clinical patient parameters. The Benjamin-Hochberg method was used for adjustment of
p-values [29]. Ordination analysis was performed using Non-metric Multidimensional Scaling
(NMDS) to investigate patterns in community composition.
Results
RYGB surgery changes mycobiome diversity
Bacterial and fungal alpha-diversity was comparable between in RYGB patients before surgery
and the healthy control cohort (Fig 1A and 1B). After surgery, a trend for an increase in bacte-
rial alpha-diversity was observed when compared to patients before surgery in measures of
estimated alpha-diversity (ACE and Chao1). There was, however, no noticeable change in the
number of observed bacterial species (Sobs) and Shannon diversity (Fig 1A). In contrast, for
fungi we observed a significant reduction in estimated (Chao1, P = 0.03) and observed (Sobs,
P = 0.01) species richness and Shannon diversity (P = 0.01, Fig 1B).
For bacterial composition, PerMANOVA suggested significant differences between RYGB
patients before surgery and the healthy control cohort (P = 0.005). The effect of surgery on
microbial composition and structure was very distinct and unidirectionally resulting in signifi-
cant differences between patients before and after surgery (P = 0.001). Patients after surgery
were, however, still distinct from the healthy control cohort (P = 0.001, Fig 1C). For fungal
microbiota, NMDS analysis revealed no differences between RYGB patients before surgery
and the control cohort. However, in patients after surgery, we observed a clear alteration in
composition and structure when compared to before surgery that in contrast to the homoge-
neous shift in bacterial beta-diversity was specific to individuals and, therefore, not signifi-
cantly different between groups (Fig 1D).
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Bacterial microbiota composition changes after surgery
The microbiota of RYGB patients and normal-weight controls was dominated by Firmicutes,
specifically by members of the Clostridia class. Several significant differences in normalized
abundance at all taxonomical levels were observed between groups (Fig 2 and S1 Fig). At the
phylum level, pre-surgery patients had significantly higher levels of Firmicutes and Actinobac-
teria and lower levels of Verrucomicrobia when compared to healthy controls (P� 0.05, respec-
tively). Post-surgery, abundances of these bacterial groups were not significantly different
anymore, indicating a rebiosis of microbiota (Fig 2A and 2B). Proteobacteria levels were signif-
icantly different between all groups (P� 0.05, respectively) with healthy controls showing the
lowest levels and patients after surgery the highest (Fig 2A and 2B). At the genus level, patients
before surgery had significantly higher levels of Blautia and Roseburia when compared with
healthy controls (P� 0.05, respectively) which decreased post-surgery in the direction of a
healthy microbiome (Fig 2C and 2D). Abundances of Faecalibacterium and Bifidobacterium
also decreased after surgery. However, this decrease was beyond abundances observed in
healthy controls (Fig 2C and 2D). In line with observations at family and class level (S1 Fig),
aerotolerant Streptococcus was significantly increased after surgery (P� 0.05, respectively).
RYGB induces fungal microbiota changes at individual level
As mentioned, changes in fungal microbiota composition in response RYGB surgery were
observed on an individual level. There was, however, no unidirectional change towards, or
Fig 1. Alpha diversity of observed species of bacterial (A) and fungal (B) microbiota composition in patients before and after RYGB surgery and the
healthy control cohort. Analysis of variance (ANOVA) was performed to test global differences in diversity among groups, in addition, paired t-tests was
applied to compare RYGB patients before and after surgery. Non-metric Multi Dimensional Scaling (NMDS) plots were generated using Bray-Curtis
distances (Beta diversity) for bacterial (C) and fungal (D) microbiota genera. Data were analyzed with PerMANOVA to determine community
composition variation across groups at different taxonomic levels. P-value adjustment was done via p.adjust function using the Benjamini & Hochberg
method.
https://doi.org/10.1371/journal.pone.0236936.g001
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against, a healthy microbiome (Fig 1). This effect resulted in a lack of significant changes in
normalized abundance at all taxonomical levels (Fig 3 and S2 Fig). Ascomycota and Basidiomy-
cota were the most dominant fungal phyla in all subjects, and RYGB surgery induced a change
of these fungal groups towards a healthy microbial profile (Fig 3A and 3B). Candida, Saccharo-
myces, and Pichia were among the most abundant fungi at the genus level with decreases in
Candida and Saccharomyces and increases in Pichia after surgery (Fig 3C and 3D). When com-
pared to healthy controls, changes in Saccharomyces were towards, and changes in Candida
and Pichia, against, a healthy mycobiome. Cladosporium was less abundant in patients before
surgery when compared with healthy controls. However, surgery increased its abundances
towards a healthy mycobiome. In contrast, Cryptococcus was observed to be less abundant
before surgery when compared with healthy controls, and this trend increased after surgery
(Fig 3C and 3D).
Associations between fungal and bacterial microbiota and clinical
parameters
To further understand the interactions between bacterial and fungal groups in healthy subjects
and RYGB patients, correlation analysis was performed in all three study groups separately. In
healthy subjects, we found six positive correlations (Fig 4A) and three negative correlations
Fig 2. Normalized mean abundance ± SEM (left) and relative abundance counts (right) for major bacteria at phylum (A and B) and genus (C and
D) level in RYGB patients before and 3 month after surgery and in healthy controls. Minor bacteria are grouped under ‘Other’. Differential
abundance test was done by DESeq2 and considered to be significant at p<0.05, where (1) indicates differentially between control and after surgery, (2)
between control and before surgery, and (3) between before surgery and after surgery.
https://doi.org/10.1371/journal.pone.0236936.g002
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while we failed to identify such inter-kingdom correlation in RYGB subjects before and after
surgery.
We also identified several significant correlations between fungal and bacterial genera and
clinical patient parameters before and after surgery (Fig 4B). For fungal genera before surgery,
Saccharomyces and Pichia correlated negatively with fasting glucose and Cladosporium nega-
tively with BMI. After surgery, we lost these correlations but identified a negative correlation
between Pichia and triglycerides and a positive correlation between Debaryomyces and fasting
glucose (Fig 4B). For bacterial genera before surgery, Blautia correlated positively with HDL
cholesterol and negatively with BMI, while Streptococcus correlated negatively with triglycer-
ides. After surgery, we were again unable to find any of those correlations. However, there
were positive correlations between Roseburia and cholesterol (total and LDL), as well as
between one unclassified Lachnospiraceae bacterium and Escherichia/Shigella and LDL choles-
terol. Furthermore, Streptococcus correlated negatively with HDL cholesterol (Fig 4B).
Discussion
We characterized fungal and bacterial microbial composition in fecal samples of morbidly
obese patients before and 3 months after RYGB surgery and compared with a healthy control
cohort. We found clear but highly individualized changes in the fungal kingdom with a signifi-
cant reduction in mycobiome richness and diversity in patients after surgery when compared
to before surgery. This effect strikingly contrasts the well-described and uniform changes in
bacteria towards increased richness and diversity post-surgery.
Consistent with many other studies, we found the gut mycobiome was dominated by fungi
from the Ascomycota and Basidiomycota phyla [18, 19, 21] while Candida, Saccharomyces, and
Cladosporium were the main genera [30–32]. Ascomycota appeared more prevalent in obese
Fig 3. Normalized mean abundance ± SEM (left) and relative abundance counts (right) for major fungi at phylum (A and B) and genus (C and D)
level in RYGB patients before and 3 month after surgery and in healthy controls. Minor fungi are grouped under ‘Other’. There were no significant
differences between subject groups.
https://doi.org/10.1371/journal.pone.0236936.g003
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patients before surgery than after surgery and normal-weight controls while at genus level sim-
ilar trends were observed for Saccharomyces and Debaryomyces. These observations are in line
with a previous study comparing the fungal microbiome of 52 obese and non-obese patients
[21], possibly indicating an effect of the obese phenotype on fungal microbiota composition.
We also found a tendency for higher levels of Candida in obese patients before surgery than
Fig 4. Heatmap of Spearman’s pairwise correlation coefficients between fungi and bacterial microbiota at genus
level (A) and with metabolic parameters before and after surgery (B). Only the top 20 abundant bacterial and top 8
fungi are shown. Blue squares indicate positive correlations, and red squares indicate inverse correlations. The shading
of squares indicates the magnitude of the association; darker shades are more strongly associated than lighter shades.
P< 0.05 significance denoted by �. BMI, body mass index; HbA1c, haemoglobin A1c; HDL, high-density-lipoprotein;
LDL, low-density lipoprotein, CRP, C-reactive protein.
https://doi.org/10.1371/journal.pone.0236936.g004
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after surgery supporting a link of Candida with metabolic changes and intestinal inflammation
as previously observed for diabetes [33] and IBD [34].
There was no significant difference in fungal alpha-diversity between obese patients before
surgery and the healthy control cohort used in this study. Other studies in patients with IBD
and chronic hepatitis showed increased alpha-diversity when compared with healthy subjects
[20, 35, 36] while one recent study also observed reduced alpha-diversity in IBD patients [18].
Rodrı́guez et al. [21] observed no significant difference in fungal alpha-diversity between
obese and non-obese subjects which is consistent with our findings. Interestingly, we found
that RYGB surgery resulted in a significant reduction in observed and estimated fungal rich-
ness and diversity. This clearly contrasts the many reports of increased bacterial alpha-diver-
sity after RYGB surgery [14–16, 37–39] although in the current study we were not able to
replicate these earlier observations but only observed a trend for increased alpha-diversity
measures (ACE and Chao1). Perhaps this is due to the limited number of subjects in our study
(n = 16) when compared to earlier studies (n = 31 and 61) [14, 37], and/or different sample
times after surgery. In fact, it is likely that the gut microbiota still changes between 3 month
and 1 year after surgery to dynamically adapt to alterations in host metabolism (weight loss, fat
mass loss, etc.). Thus, further investigation is warranted to better understand changes in bacte-
rial and fungal microbiome over time and whether there are opposite changes of fungal and
bacterial diversity in relation to host disease and pathogenesis.
With regard to the bacterial microbiota, we found the typical increase in the relative abun-
dance of Proteobacteria after surgery [14–16, 37–39]. While due to their proinflammatory
properties Proteobacteria are generally not considered to be beneficial [40, 41], there was no
increase in CRP levels after surgery in our cohort (Table 1). This Proteobacteria increase might
reflect the increase in oxygen availability in the large intestine after surgery, favoring facultative
anaerobes such as Escherichia, Klebsiella, and Pseudomonas [42, 43]. Along the same lines, we
observed a decrease in obligatory anaerobic gram-positive bacterial groups such as Blautia,
Roseburia and Faecalibacterium from the phylum Firmicutes as well as Bifidobacterium from
the phylum Actinobacteria [15, 16, 39]. It is possible that these compositional changes are also
linked to (i) reduced gastric acid secretion after surgery [44], (ii) reduction in total energy
intake with modifications in nutrient composition and (iii) increased availability of undigested
nutrients in the large intestine due to the anatomic alteration after surgery.
Interestingly, RYGB surgery resulted in individualized changes in the fungal microbiota
and not in unidirectional changes, as observed for bacterial microbiota. One explanation is
that fungi are aerobic and thus less sensitive to the increase in oxygen availability after sur-
gery. This may limit unidirectional changes as seen with bacteria that are highly sensitive to
such gastrointestinal conditions. Moreover, while it is known that eating habits can influ-
ence the bacterial gut microbiota, there may be an even stronger influence of daily diet on
the gut mycobiome. This is supported by a study by Hallen-Adams et al. [45], which ana-
lyzed the composition of the gut mycobiome at two time points each from 24 participants
and found detection of the same fungus occurred in less than 20% of the time. Also David
et al. [46] conducted a controlled diet study and found while bacterial composition showed
a clear response to nutrient availability (carbohydrates/fiber vs. proteins and fats), fungal
composition appeared to be driven by food colonization with the same species of fungi
detected in participant fecal samples and in cheese fed to those participants. In fact,
sequencing methods do not distinguish between DNA contributed from live or dead cells.
Thus, it is not possible to differentiate fungi colonizing the gut from transients derived from
diet and/or environment. Among the most dominant genera in our cohorts were Saccharo-
myces and Debaryomyces which are both commonly found in foods such as mushrooms,
cheese, bread and beer.
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We also performed correlation analyses to identify inter-kingdom relations and associa-
tions of bacterial and fungal microbiota with anthropometric and metabolic parameters. Sev-
eral studies suggested a direct interaction of fungi and bacteria. In IBD, Sokol et al. [18]
reported disease-specific patterns for inter-kingdom networks with increased strenghts of cor-
relations between fungi and bacteria in ulcerative colitis but weaker correlations in Crohn´s
disease. We observed several significant correlations between bacteria and fungi in healthy,
normal-weight controls but not in RYGB patients, which may indicate persistence of a dysbio-
tic microbiota state in the obese before and after surgery. Moreover, we found that Pichia was
negatively correlated with fasting glucose before surgery and with triglycerides after surgery,
while Streptococcus was negatively correlated with triglycerides before surgery and with HDL
after surgery. These metabolic and microbial changes might be independent results of the sur-
gical intervention. However, it warrants further research to investigate if the correlated fungal
and bacterial groups might also directly modulate metabolic parameters independent of sur-
gery. Such direct effects could be tested in a RYGB rat model with a targeted fungicide/antibi-
otic intervention.
There are some limitations of our study. 1) In this pilot study, we only included 16 RYGB
patients and 9 healthy control subject, thus, whether our data are representative of larger
cohorts remains to be proven. 2) The healthy subject cohort which was used as a baseline to
interpret the direction of changes in our main patient cohort was sampled at a distinct place
using a different sampling method and was not adjusted for age and gender. Since geography
including different eating habits, sampling methodology, age and gender can all impact micro-
biome measurements, caution is required when directly comparing these two cohorts. 3) Fun-
gal and bacterial microbial composition was characterized only before and three months after
surgery. While this allows to better understand the immediate effects of surgery, it does not
provide information on the dynamic changes that may occur later in the postoperative phase
as an adaption to changes in host metabolism such as weight loss, fat mass loss, etc. 4)) All cur-
rent sequencing technologies only asses DNA signatures and thus cannot distinguish between
DNA contributed from colonizing cells or fungi or transients derived from the diet. 5) Associ-
ations between specific fungi and 3-month clinical data such as cholesterol values need to be
confirmed with a longer follow-up.
In conclusion, we found a clear alteration in structure and composition of fungal and bacte-
rial microbiota in response to RYGB surgery. Beta diversity analysis revealed significant differ-
ences in bacterial microbiota between obese patients before surgery and healthy controls
(P< 0.005) and a significant, unidirectional shift in RYGB patients after surgery (P< 0.001 vs.
before surgery). In contrast, there was no significant difference in fungal microbiota between
groups but individually specific changes after RYGB surgery. Interestingly, RYGB surgery
induced a significant reduction in fungal alpha diversity namely Chao1, Sobs, and Shannon
diversity index (P<0.05, respectively) which contrasts the trend for uniform changes in bacteria
towards increased richness and diversity post-surgery. We did not observe any inter-kingdom
relations in RYGB patients but in the healthy control cohort and there were several correla-
tions between fungi and bacteria and clinical parameters (P<0.05, respectively) that warrant
further research.
Supporting information
S1 File. Supplementary material and methods.
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S1 Fig. Normalized mean abundance +/- SEM (left) and relative abundance counts (right)
for major bacteria at class (A and B) and family (C and D) level in RYGB patients before
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and 3 month after surgery and in healthy controls. Minor bacteria are grouped under
‘Other’. Differential abundance test was done by DESeq2 and considered to be significant at
p<0.05, where (1) indicates differentially between control and after surgery, (2) between con-
trol and before surgery, and (3) between before surgery and after surgery.
(TIFF)
S2 Fig. Normalized mean abundance +/- SEM (left) and relative abundance counts (right)
for major fungi at class (A and B) and family (C and D) level in RYGB patients before and
3 month after surgery and in healthy controls. Minor fungi are grouped under ‘Other’.
There were no significant differences between subject groups.
(TIFF)
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